Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Find a clinical trial that's recruiting now
Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.
- 24,857
- trials recruiting now
- 14%
- of all US trials open to enrollment
- 52
- states with recruiting sites
A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.
Popular conditions
100 trials found
Connect for Cancer Prevention Study (Connect)
National Cancer Institute (NCI)
NCT04609072
Stroke Thrombectomy and Aneurysm Registry
Medical University of South Carolina
NCT04994756
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Foundation
NCT04994015
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
NCT06995898
Umbrella Study for Analysis of Data Related to Patients With Cancer
Tempus AI
NCT06018753
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
VA Office of Research and Development
NCT02915198
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University
NCT04278404
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
NCT05297734
Study of Student Flourishing
Flourish Science
NCT07259746
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Uppsala University
NCT02901184
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Eli Lilly and Company
NCT07321886
'Ai Pono Cooking Demonstrations
University of Hawaii
NCT06526650
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Bristol-Myers Squibb
NCT05489705
EXoPERT EMERALD Clinical Study
EXoPERT
NCT07186296
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
NCT07207811
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals
NCT07225504
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Eli Lilly and Company
NCT06143956
GEMINI-NSCLC: NSCLC Biomarker Study
Tempus AI
NCT05236114
Brain Oxygen Optimization in Severe TBI, Phase 3
University of Michigan
NCT03754114
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
M.D. Anderson Cancer Center
NCT04739072
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Merz Therapeutics
NCT07018700
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
NCT06989437
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly and Company
NCT06948422
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
U.S. Army Medical Research and Development Command
NCT04180930
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Hoffmann-La Roche
NCT07174310
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
Global Coalition for Adaptive Research
NCT05422612
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Hoffmann-La Roche
NCT07169578
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio
NCT05150691
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Merz Therapeutics
NCT07018713
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
SWOG Cancer Research Network
NCT05642611
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Pfizer
NCT07431853
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
AstraZeneca
NCT07044336
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
NCT07284849
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie
NCT04928846
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
University of Rochester
NCT05006482
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
NCT07216742
Contraceptive Efficacy Study of Ovaprene
Daré Bioscience
NCT06127199
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
AstraZeneca
NCT06103864
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
NRG Oncology
NCT06279013
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
Eli Lilly and Company
NCT07357415
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
University of Hawaii
NCT05369546
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
AstraZeneca
NCT06989112
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca
NCT06350097
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
AstraZeneca
NCT06346392
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
University of Michigan
NCT05388708
Multisite Advancement of Research on Chronic Posttraumatic Headache
The University of Texas Health Science Center at San Antonio
NCT05620719
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Giselle Sholler
NCT02559778
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Luminopia
NCT06429280
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
Eli Lilly and Company
NCT06948435
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Eli Lilly and Company
NCT06952530
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Dianthus Therapeutics
NCT06858579
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Alliance for Clinical Trials in Oncology
NCT06632977
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Amgen
NCT06700343
Neuroblastoma Maintenance Therapy Trial
Giselle Sholler
NCT02679144
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Children's Oncology Group
NCT01790152
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Novartis Pharmaceuticals
NCT07094516
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment
University of Rochester NCORP Research Base
NCT04829539
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
National Cancer Institute (NCI)
NCT04530565
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
NCT05554406
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Children's Oncology Group
NCT05702645
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
AstraZeneca
NCT05261399
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Milton S. Hershey Medical Center
NCT06465199
The Healthy Diet and Lifestyle Study II
University of Hawaii
NCT05132686
Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C)
Henry M. Jackson Foundation for the Advancement of Military Medicine
NCT06855186
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
ONY
NCT05960929
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Daiichi Sankyo
NCT06244485
PILI 'Āina Household
University of Hawaii
NCT06526273
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
Global Coalition for Adaptive Research
NCT05948553
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Global Coalition for Adaptive Research
NCT05948540
Natives Engaged in Alzheimers Research - 'Ike Kupuna
University of Hawaii
NCT05534607
Emovi 3D Knee Assessment Device Intervention for Operational Readiness
Womack Army Medical Center
NCT06517056
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
Hawaii Pacific Health
NCT04399707
Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device
Microvention-Terumo
NCT04839705
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals
NCT07029581
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Boehringer Ingelheim
NCT06321302
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
National Cancer Institute (NCI)
NCT05554328
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals
NCT05667142
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Avantec Vascular
NCT06321575
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie
NCT06568939
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
NCT05136196
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
Novartis Pharmaceuticals
NCT06517758
The Lilac Device Trial
Luminate Medical
NCT07142304
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
Kaiser Permanente
NCT05991882
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
M.D. Anderson Cancer Center
NCT02945579
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Giselle Sholler
NCT04696029
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Milton S. Hershey Medical Center
NCT06541262
Rehabilitation With Empowered STrategies to Optimize REcovery
Vanderbilt University Medical Center
NCT07406997
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience
NCT07002034
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Giselle Sholler
NCT06540963
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
PedAL BCU
NCT05183035
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Wake Forest University Health Sciences
NCT06904391
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Giselle Sholler
NCT05489887
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
NCT07015983
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
Queen's Medical Center
NCT04965454
Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy
Vanderbilt University Medical Center
NCT06202443
Quit-Smoking Study for Native Hawaiians
University of Hawaii
NCT07075575
Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
Queen's Medical Center
NCT06951438
Weight Loss and Physical Fitness Following Pregnancy in Active Duty Women
Tripler Army Medical Center
NCT05518604
Vapocoolant Spray to Reduce Pain With Nexplanon Insertion
Queen's Medical Center
NCT06933381
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
OncoTherapy Science
NCT02926690
Read our methodology - how recruiting status is sourced and refreshed from the public registry.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.